• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

BioCardia

BioCardia raises $8.5M

December 15, 2020 By Sean Whooley

BioCardia (OTC:BCDA) announced that it entered into a securities purchase agreement for the sale of shares worth approximately $8.5 million. San Carlos, Calif.-based BioCardia’s agreement includes the sale and issuance of an aggregate of nearly 1.8 million shares at an offering price of $4.75 per share, totaling the gross proceeds of approximately $8.5 million before deductions […]

Filed Under: Business/Financial News, Cardiovascular, Funding Roundup Tagged With: BioCardia

BioCardia announces $11.5m offering

June 15, 2020 By Sean Whooley

Heart failure therapy developer BioCardia (OTC:BCDA) announced that it is offering shares of common stock worth $11.5 million. The San Carlos, Calif.-based company is offering nearly 2.9 million shares of its common stock at a $0.001 par value per share. It is also offering an opportunity for certain purchasers whose purchase would otherwise result in it […]

Filed Under: Business/Financial News, Cardiovascular, Funding Roundup, Wall Street Beat Tagged With: BioCardia

BioCardia wins CE Mark renewal for Helix, Morph catheters

October 9, 2019 By Sean Whooley

BioCardia (OTC:BCDA) said yesterday that it won CE Mark renewal for its Helix biotherapeutic delivery catheter and Morph universal deflectable guide catheter for delivery of biotherapeutics to the heart. With the renewed CE Mark, BioCardia said it can continue supporting partners outside the U.S. and move forward with commercial sales of the Helix and Morph systems […]

Filed Under: Cardiovascular, Regenerative Medicine, Regulatory/Compliance Tagged With: BioCardia

BioCardia registers for $18m offering

April 10, 2019 By Fink Densford

BioCardia (NSDQ:BCDA) has registered for an upcoming offering of its common stock, looking to raise approximately $18 millions according to an SEC filing. The company has not yet set a price range for the offering, nor has it stated how many shares it is looking to float. San Carlos, Calif.-based BioCardia did note the closing price […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: BioCardia

Bone adhesive dev Launchpad Medical raises $9m | Medtech Funding Roundup

January 10, 2019 By Fink Densford

Launchpad Medical has raised $8.5 million in a new round of equity financing, according to recently posted SEC filings. The Lowell, Mass.-based medtech company is developing the Tetranite injectable, synthetic adhesive solution intended for bone repair. Tetranite is bioresorbable and is designed to provide instant adhesive capabilities to treat fractured bone and to stabilize metal […]

Filed Under: Business/Financial News, Featured, Wall Street Beat Tagged With: ALung Technologies Inc., babyscripts, BioCardia, conextionsmedical, Conventus Orthopaedics, cynerio, decisionsciencesmedical, Jarvik Heart, launchpadmedical, Leviticus Cardio, Philips, seraphbiosciences

BioCardia submits bid for FDA clearance of Avance transseptal introducer

December 11, 2018 By Fink Densford

BioCardia (NSDQ:BCDA) said today that it submitted an application for FDA 510(k) clearance for its Avance steerable introducer intended for introducing cardiovascular catheters into the heart, including the left side of the heart through the interatrial septum. The San Carlos, Calif.-based company said the Avance device uses new technology developed for the company’s Morph line of […]

Filed Under: 510(k), Cardiovascular, Catheters, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: BioCardia

Google taps ex-Geisinger CEO Feinberg to lead consolidated Google Health biz | Personnel Moves – November 14, 2018

November 14, 2018 By Fink Densford

Google (NSDQ:GOOG) has picked up former Geisinger Health CEO David Feinberg to lead its fragmented health divisions under the Google Health moniker, according to a recent CNBC report. The tech giant had been searching for a head for several months, with artificial intelligence head Jeff Dean heavily involved in the process, according to the report. Other […]

Filed Under: Business/Financial News, Featured Tagged With: Accuray Inc., Alphabet (Google), BioCardia, Bovie Medical Corp., Clearside Biomedical, Eos Imaging, Geisinger Health System, Getinge, hancockjaffelabs, Intact Vascular, Integra LifeSciences, Intuitive Surgical, mperiatherapeutics, Owens and Minor, Procept BioRobotics, Profound Medical Inc., Verily

BioCardia touts preliminary data from heart failure trial

August 23, 2018 By Sarah Faulkner

BioCardia (OTC:BCDA) touted data today from the first 10 patients treated in its Phase III CardiAmp heart failure trial. The company’s investigational therapy uses a patient’s bone marrow cells to trigger the body’s natural ability to heal itself, according to BioCardia. These data are the first to be published from any pivotal trial of a stem […]

Filed Under: Cardiovascular, Clinical Trials, Regenerative Medicine, Wall Street Beat Tagged With: BioCardia

Report: Amazon adds MGH cardiologist Majmudar | Personnel Moves – August 21, 2018

August 21, 2018 By Fink Densford

Amazon (NSDQ:AMZN) has picked up well-known cardiologist Dr. Maulik Majmudar for a new role within the company as it looks to continue its foray into healthcare, according to a recent CNBC report. The announcement was made by Majmudar himself on Twitter, according to the report, though he did not state what his specific role within the […]

Filed Under: Business/Financial News Tagged With: Abbott, Amazon, BioCardia, BioSig Technologies, Endologix, Johnson and Johnson, Lantheus, Lumendi, Nuvasive, Personnel Moves, Philips, Rox Medical, SetPoint Medical, Steris Corp., Xtant Medical

BioCardia wins FDA nod for chronic myocardial ischemia pivotal trial

January 30, 2018 By Sarah Faulkner

The FDA has approved a trial to test BioCardia‘s (OTC:BCDA) CardiAMP cell therapy in chronic myocardial ischemia patients with refractory angina. The San Carlos, Calif.-based company could enroll up to 343 patients in the pivotal trial, which is designed to support benefit claims for the cell therapy product without the need for a second confirmatory trial. […]

Filed Under: Cardiovascular, Clinical Trials, Drug-Device Combinations, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance, Vascular, Wall Street Beat Tagged With: BioCardia

BioCardia files 2nd FDA IDE bid for CardiAMP chronic myocardial ischemia, refractory angina study

January 5, 2018 By Fink Densford

BioCardia (NSDQ:BCDA) said today it filed for a second FDA investigational device exemption to launch a trial of its CardiAMP cell therapy of chronic myocardial ischemia and refractory angina as it seeks a second indication. The San Carlos, Calif.-based company’s CardiAMP therapy uses autologous cells to treat chronic myocardial ischemia, and is designed to stimulate the […]

Filed Under: Clinical Trials, Food & Drug Administration (FDA), Regenerative Medicine Tagged With: BioCardia

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS